Partnership Opportunities

Partner With Us in 2024

Through extensive research with industry leaders from Pfizer, Sanofi, Bayer, BioNTech and the FDA within the LNP field, it is clear that understanding the full extent to which we can use LNP-based drugs for vaccines, gene editing, oncology applications, and payloads beyond mRNA is a great challenge, and further to that, the capacity of the service providers available to them. This is a major bottleneck, with high pressured timelines in the race to deliver safe and effective therapeutic products to patients in need.

If you are a contract service or technology provider with the analytical experience and specific technologies to meet this exploding markets’ demands, then the LNP Immunogenicity & Toxicity Summit will provide a platform for you to showcase your solutions to a niche audience of experts from the field.

In 2023 we joined forces with industry pioneers to reveal their vendor pain points:

We want vendors who are willing to work with us, help troubleshoot, be part of the process

One major pain point has been the lead times for materials

Flexible processes offered that fit the need of the progression of the therapy

Experts within the field are looking for partners in: Computational Chemistry & Imaging, Pre-Clinical Models, Tox/PKPD experts, Immunogenicity screening/potency/bioassays and need your help with:


Immunogenicity Screening & Assays

Preparing appropriate preclinical models

Computational Chemistry & Imaging services

And more!

Hear From Our 2nd LNP Formulation & Process Development Summit Partners

LNP Summit-146

Why Partner?

2nd LNP Immunogenicity & Toxicity Summit - Why Partner